Book contents
- Uncommon Causes of Stroke
- Uncommon Causes of Stroke
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 Infectious Conditions
- Section 2 Inflammatory Conditions
- Section 3 Hereditary and Genetic Conditions and Malformations
- Chapter 16 Pulmonary Arteriovenous Malformations
- Chapter 17 Hereditary Hemorrhagic Telangiectasia
- Chapter 18 Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
- Chapter 19 Cerebral Autosomal-Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)
- Chapter 20 Sickle Cell Disease and Other Hemoglobinopathies
- Chapter 21 Cerebrovascular Complications of Fabry Disease*
- Chapter 22 Marfan Syndrome
- Chapter 23 Pseudoxanthoma Elasticum
- Chapter 24 Ehlers–Danlos Syndrome
- Chapter 25 Progeria
- Chapter 26 MELAS Syndrome and Other Mitochondrial Disorders
- Chapter 27 Sturge–Weber Syndrome
- Chapter 28 Von Hippel–Lindau Disease
- Chapter 29 Familial Aneurysms
- Chapter 30 Cerebral Cavernous Malformations and Developmental Venous Anomalies
- Chapter 31 Cerebrovascular Manifestations of Neurofibromatosis
- Chapter 32 Menkes Disease
- Chapter 33 Wyburn–Mason Syndrome
- Chapter 34 Divry–van Bogaert Syndrome
- Chapter 35 Blue Rubber Bleb Syndrome
- Section 4 Vascular Conditions of the Eyes, Ears, and Brain
- Section 5 Disorders Involving Abnormal Coagulation
- Section 6 Systemic Disorders That Also Involve the Cerebrovascular System
- Section 7 Non-Inflammatory Disorders of the Arterial Wall
- Section 8 Venous Occlusive Conditions
- Section 9 Vasospastic Conditions and Other Miscellaneous Vasculopathies
- Index
- Plate Section (PDF Only)
- References
Chapter 26 - MELAS Syndrome and Other Mitochondrial Disorders
from Section 3 - Hereditary and Genetic Conditions and Malformations
Published online by Cambridge University Press: 15 June 2018
Book contents
- Uncommon Causes of Stroke
- Uncommon Causes of Stroke
- Copyright page
- Contents
- Contributors
- Preface
- Section 1 Infectious Conditions
- Section 2 Inflammatory Conditions
- Section 3 Hereditary and Genetic Conditions and Malformations
- Chapter 16 Pulmonary Arteriovenous Malformations
- Chapter 17 Hereditary Hemorrhagic Telangiectasia
- Chapter 18 Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL)
- Chapter 19 Cerebral Autosomal-Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL)
- Chapter 20 Sickle Cell Disease and Other Hemoglobinopathies
- Chapter 21 Cerebrovascular Complications of Fabry Disease*
- Chapter 22 Marfan Syndrome
- Chapter 23 Pseudoxanthoma Elasticum
- Chapter 24 Ehlers–Danlos Syndrome
- Chapter 25 Progeria
- Chapter 26 MELAS Syndrome and Other Mitochondrial Disorders
- Chapter 27 Sturge–Weber Syndrome
- Chapter 28 Von Hippel–Lindau Disease
- Chapter 29 Familial Aneurysms
- Chapter 30 Cerebral Cavernous Malformations and Developmental Venous Anomalies
- Chapter 31 Cerebrovascular Manifestations of Neurofibromatosis
- Chapter 32 Menkes Disease
- Chapter 33 Wyburn–Mason Syndrome
- Chapter 34 Divry–van Bogaert Syndrome
- Chapter 35 Blue Rubber Bleb Syndrome
- Section 4 Vascular Conditions of the Eyes, Ears, and Brain
- Section 5 Disorders Involving Abnormal Coagulation
- Section 6 Systemic Disorders That Also Involve the Cerebrovascular System
- Section 7 Non-Inflammatory Disorders of the Arterial Wall
- Section 8 Venous Occlusive Conditions
- Section 9 Vasospastic Conditions and Other Miscellaneous Vasculopathies
- Index
- Plate Section (PDF Only)
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Uncommon Causes of Stroke , pp. 194 - 199Publisher: Cambridge University PressPrint publication year: 2018
References
Al-Hassnan, Z. N., Rashed, M. S., Al-Dirbashi, O. Y., et al. 2008. Hyperornithinemia–hyperammonemia–homocitrullinuria syndrome with stroke-like imaging presentation: Clinical, biochemical and molecular analysis, J Neurol Sci, 264: 187–94.Google Scholar
Bersano, A., Markus, H. S., Quaglini, S., et al. 2016. Clinical pregenetic screening for stroke monogenic diseases: Results from Lombardia GENS Registry, Stroke, 47: 1702–9.Google Scholar
Betts, J., Jaros, E., Perry, R. H., et al. 2006. Molecular neuropathology of MELAS: Level of heteroplasmy in individual neurones and evidence of extensive vascular involvement, Neuropathol Appl Neurobiol, 32: 359–73.Google Scholar
Calfee, C. S. and Matthay, M. A.. 2010. Clinical immunology: Culprits with evolutionary ties, Nature, 464: 41–2.Google Scholar
Chan, D. C. 2006. Mitochondria: Dynamic organelles in disease, aging, and development, Cell, 125: 1241–52.Google Scholar
Chomyn, A., Enriquez, J. A., Micol, V., Fernandez-Silva, P., and Attardi, G.. 2000. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episode syndrome-associated human mitochondrial tRNALeu(UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes, J Biol Chem, 275: 19198–209.Google Scholar
Deschauer, M., Tennant, S., Rokicka, A., et al. 2007. MELAS associated with mutations in the POLG1 gene, Neurology, 68: 1741–2.Google Scholar
Desquiret-Dumas, V., Gueguen, N., Barth, M. et al. 2012. Metabolically induced heteroplasmy shifting and L-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS, Biochim Biophys Acta, 1822: 1019–29.Google Scholar
DiMauro, S. and Hirano, M.. 1993. MELAS. In Pagon, R. A., Adam, M. P., Ardinger, H. H., et al. (eds.), GeneReviews(R), Seattle, WA: University of Washington.Google Scholar
DiMauro, S., Schon, E. A., Carelli, V., and Hirano, M.. 2013. The clinical maze of mitochondrial neurology, Nat Rev Neurol, 9: 429–44.Google Scholar
El-Hattab, A. W., Hsu, J. W., Emrick, L. T., et al. 2012. Restoration of impaired nitric oxide production in MELAS syndrome with citrulline and arginine supplementation, Mol Genet Metab, 105: 607–14.Google Scholar
El-Hattab, A. W., Adesina, A. M., Jones, J., and Scaglia, F.. 2015. MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options, Mol Genet Metab, 116: 4–12.Google Scholar
Finsterer, J. 2009. Management of mitochondrial stroke-like-episodes, Eur J Neurol, 16: 1178–84.Google Scholar
Frederiksen, A. L., Andersen, P. H., Kyvik, K. O., et al. 2006. Tissue specific distribution of the 3243A>G mtDNA mutation, J Med Genet, 43: 671–7.Google Scholar
Giles, R. E., Blanc, H., Cann, H. M., and Wallace, D. C.. 1980. Maternal inheritance of human mitochondrial DNA, Proc Natl Acad Sci U S A, 77: 6715–9.Google Scholar
Gorman, G. S., Schaefer, A. M., Ng, Y., et al. 2015. Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease, Ann Neurol, 77: 753–9.Google Scholar
Goto, Y., Nonaka, I., and Horai, S.. 1990. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies, Nature, 348: 651–3.Google Scholar
Goto, Y., Horai, S., Matsuoka, T., et al. 1992. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): A correlative study of the clinical features and mitochondrial DNA mutation, Neurology, 42: 545–50.CrossRefGoogle Scholar
Hamalainen, R. H., Manninen, T., Koivumaki, H., et al. 2013. Tissue- and cell-type-specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model, Proc Natl Acad Sci USA, 110: E3622–30.Google Scholar
Hasegawa, H., Matsuoka, T., Goto, Y., and Nonaka, I.. 1991. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes, Ann Neurol, 29: 601–5.Google Scholar
Hess, J. F., Parisi, M. A., Bennett, J. L., and Clayton, D. A.. 1991. Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies, Nature, 351: 236–9.Google Scholar
Hirano, M. and Pavlakis, S. G.. 1994. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): Current concepts, J Child Neurol, 9: 4–13.Google Scholar
Hirano, M., Ricci, E., Koenigsberger, M. R., et al. 1992. MELAS: An original case and clinical criteria for diagnosis, Neuromuscul Disord, 2: 125–35.Google Scholar
Kaufmann, P., Koga, Y., Shanske, S., et al. 1996. Mitochondrial DNA and RNA processing in MELAS, Ann Neurol, 40: 172–80.Google Scholar
King, M. P., Koga, Y., Davidson, M., and Schon, E. A.. 1992. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes, Mol Cell Biol, 12: 480–90.Google Scholar
Kobayashi, Y., Momoi, M. Y., Tominaga, K., et al. 1990. A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes), Biochem Biophys Res Commun, 173: 816–22.Google Scholar
Koga, Y., Akita, Y., Nishioka, J., et al. 2007. MELAS and L-arginine therapy, Mitochondrion, 7: 133–9.Google Scholar
Koga, Y., Akita, Y., Nishioka, J., et al. 2005. L-arginine improves the symptoms of strokelike episodes in MELAS, Neurology, 64: 710–2.Google Scholar
Koga, Y., Povalko, N., Nishioka, J., et al. 2010. MELAS and L-arginine therapy: Pathophysiology of stroke-like episodes, Ann NY Acad Sci, 1201: 104–10.Google Scholar
Koga, Y., Povalko, N., Nishioka, J., et al. 2012. Molecular pathology of MELAS and L-arginine effects, Biochim Biophys Acta, 1820: 608–14.Google Scholar
Majamaa, K., Moilanen, J. S., Uimonen, S., et al. 1998. Epidemiology of A3243 G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: Prevalence of the mutation in an adult population, Am J Hum Genet, 63: 447–54.Google Scholar
Mancuso, M., Nesti, C., Ienco, E. C., et al. 2014. Novel MTCYB mutation in a young patient with recurrent stroke-like episodes and status epilepticus, Am J Med Genet A, 164: 2922–5.Google Scholar
Nesbitt, V., Pitceathly, R. D., Turnbull, D. M., et al. 2013. The UK MRC Mitochondrial Disease Patient Cohort Study: Clinical phenotypes associated with the m.3243A>G mutation – implications for diagnosis and management, J Neurol Neurosurg Psychiatry, 84: 936–8.Google Scholar
Pavlakis, S. G., Phillips, P. C., DiMauro, S., De Vivo, D. C., and Rowland, L. P.. 1984. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome, Ann Neurol, 16: 481–8.Google Scholar
Rossignol, R., Faustin, B., Rocher, C., et al. 2003. Mitochondrial threshold effects, Biochem J, 370: 751–62.Google Scholar
Saneto, R. P. and Sedensky, M. M.. 2013. Mitochondrial disease in childhood: mtDNA encoded, Neurotherapeutics, 10: 199–211.CrossRefGoogle ScholarPubMed
Saneto, R. P., Friedman, S. D., and Shaw, D. W.. 2008. Neuroimaging of mitochondrial disease, Mitochondrion, 8: 396–413.Google Scholar
Schaefer, A. M., McFarland, R., Blakely, E. L., et al. 2008. Prevalence of mitochondrial DNA disease in adults, Ann Neurol, 63: 35–9.Google Scholar
Sproule, D. M. and Kaufmann, P.. 2008. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: Basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome, Ann NY Acad Sci, 1142: 133–58.Google Scholar
Tatlisumak, T., Putaala, J., Innila, M., et al. 2016. Frequency of MELAS main mutation in a phenotype-targeted young ischemic stroke patient population, J Neurol, 263: 257–62.Google Scholar
Tay, S. H., Nordli, D. R. Jr., Bonilla, E., et al. 2006. Aortic rupture in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes, Arch Neurol, 63: 281–3.Google Scholar
Tzoulis, C. and Bindoff, L. A.. 2009. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, Stroke, 40: e15–7.Google Scholar
Uusimaa, J., Moilanen, J. S., Vainionpaa, L., et al. 2007. Prevalence, segregation, and phenotype of the mitochondrial DNA 3243A>G mutation in children, Ann Neurol, 62: 278–87.Google Scholar
Yasukawa, T., Suzuki, T., Ueda, T., Ohta, S., and Watanabe, K.. 2000. Modification defect at anticodon wobble nucleotide of mitochondrial tRNA(Leu)(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes, J Biol Chem, 275: 4251–7.Google Scholar
Yatsuga, S., Povalko, N., Nishioka, J., et al. 2012. MELAS: A nationwide prospective cohort study of 96 patients in Japan, Biochim Biophys Acta, 1820: 619–24.Google Scholar
- 1
- Cited by